LLSC grant recipient, Dr. Cheryl Arrowsmith, is on the leading edge of cancer research. She is an internationally recognized expert in cancer related structural biology & chemical biology and epigenetics. Her accomplishments, too numerous to mention, include:
- Senior Scientist at the Princess Margaret Cancer Centre
- Member of 18 scientific advisory boards, grant review panels and journal editorial boards
- Canada Research Chair in Structural Genomics at the University of Toronto
- Published author 250 peer reviewed articles
- Co-author 1800 3D protein structures in the Protein Data Bank (PDB)
- Leader Structural Genetics Consortium (SGC) Toronto, Co-ordinator SGC epigenetic chemical probe program
Intimidating? Perhaps on paper, but when you meet Dr. Arrowsmith, she is warm, welcoming and keen to explain her work. At a recent LLSC Journey of Hope event in Toronto, Dr. Arrowsmith opened her lab at the MaRS Centre to a group of blood cancer survivors, families and the LLSC.
Dr. Arrowsmith is tackling cancer with epigenetics and open science. Epigenetics, the study of biological mechanisms that switch genes on and off, play an important role in the development of stem cells, making it highly relevant to blood cancers which are stem cell driven.
Open Science is the movement to make scientific research, data and dissemination accessible to all levels of an inquiring society,”… enabling more investigators to carry out more impactful research, with better tools”.
As Leader of the SGC Toronto site since its inception, Dr. Arrowsmith has pushed the boundaries of open science, by making all of the SGC’s outputs- including chemical probes- publically available without any restrictions on their use. “Providing our chemical probes to the world’s scientists allows us to crowdsource and accelerate research” says Dr. Arrowsmith.